Last week, HHS finalized a new rule that requires healthcare AI developers to provide more data about their products to customers, which could aid providers in determining AI tools’ risks and effectiveness. Some AI leaders believe the new guardrails are a step in the right direction, and others are skeptical about whether the new rules are necessary or will be effective.
Through rigorous validation processes, unwavering transparency, gradual implementation, and a steadfast commitment to preserving the human touch, healthcare IT providers can unequivocally demonstrate that AI is a reliable and trustworthy ally in the intricate and evolving landscape of healthcare.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Aneesh Chopra, president and co-founder of CareJourney, predicted accelerated enrollment in value-based care models in 2024 and 2025. He thinks this will greatly increase healthcare transparency for a few reasons, including making data more available and influencing more primary care doctors to act as health information fiduciaries on behalf of their patients.
Palo Alto-based Theator makes technology to help providers understand the high level of variability in outcomes among common surgical procedures. The startup recently uncovered a key reason why patient suffer complications after hysterectomies, and it stems from the fact that surgeons lack a standardized set of safety practices to which they must adhere.
An intelligent authorization platform relies on AI and machine learning to extract patient-specific data from a number of sources including the EHR. This helps health plans better anticipate, manage and optimize member outcomes.
By engaging in a dialogue, patients and pharma companies can have a mutually beneficial relationship, Health Union's Jack Barrette said at HLTH’s patient engagement track, hosted by MedCity News. Not only can patients help mold clinical trials, but they can help companies improve their patient education efforts.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
HHS wants insurers offering individual and short-term, limited-duration coverage to disclose to members the rates they pay to brokers who help people select health plans. The government also wants to collect air ambulance data to help curb the high and unexpected costs that arise from these services.
More than half of consumers say they are likely to use recommended providers or facilities if they receive a financial reward.
Seema Verma, administrator of the Centers for Medicare and Medicaid Services, refused to discuss the findings in any detail or comment on any individual states that performed poorly or exceptionally.
Medicare officials requested comments late Thursday on how to use discounts and rebates to help decrease what enrollees pay for prescriptions.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The decision support tools can help physicians engage patients and make choices that fit within their budget, no matter what the patient's insurance is. That way, they are more likely to pick up their medication.
As we work to help biopharmaceutical and healthcare companies integrate the voice...